BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24877885)

  • 1. The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p, -155, and -199a/b-3p in human atherosclerotic coronary artery.
    Hao L; Wang XG; Cheng JD; You SZ; Ma SH; Zhong X; Quan L; Luo B
    Cardiovasc Pathol; 2014; 23(4):217-23. PubMed ID: 24877885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study.
    Raitoharju E; Lyytikäinen LP; Levula M; Oksala N; Mennander A; Tarkka M; Klopp N; Illig T; Kähönen M; Karhunen PJ; Laaksonen R; Lehtimäki T
    Atherosclerosis; 2011 Nov; 219(1):211-7. PubMed ID: 21820659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique MicroRNA signatures associated with early coronary atherosclerotic plaques.
    Wang R; Dong LD; Meng XB; Shi Q; Sun WY
    Biochem Biophys Res Commun; 2015 Aug; 464(2):574-9. PubMed ID: 26159918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells.
    Li D; Yang P; Xiong Q; Song X; Yang X; Liu L; Yuan W; Rui YC
    J Hypertens; 2010 Aug; 28(8):1646-54. PubMed ID: 20531225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiles of six circulating microRNAs critical to atherosclerosis in patients with subclinical hypothyroidism: a clinical study.
    Zhang X; Shao S; Geng H; Yu Y; Wang C; Liu Z; Yu C; Jiang X; Deng Y; Gao L; Zhao J
    J Clin Endocrinol Metab; 2014 May; 99(5):E766-74. PubMed ID: 24517143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles.
    Liu Y; Li Q; Hosen MR; Zietzer A; Flender A; Levermann P; Schmitz T; Frühwald D; Goody P; Nickenig G; Werner N; Jansen F
    Circ Res; 2019 Feb; 124(4):575-587. PubMed ID: 30582459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
    Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
    Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.
    Xu Z; Han Y; Liu J; Jiang F; Hu H; Wang Y; Liu Q; Gong Y; Li X
    Sci Rep; 2015 Jul; 5():12276. PubMed ID: 26184978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of microRNA-330 on vulnerable atherosclerotic plaques formation and vascular endothelial cell proliferation through the WNT signaling pathway in acute coronary syndrome.
    Ren J; Ma R; Zhang ZB; Li Y; Lei P; Men JL
    J Cell Biochem; 2018 Jun; 119(6):4514-4527. PubMed ID: 29236323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs.
    Fan X; Wang E; Wang X; Cong X; Chen X
    Exp Mol Pathol; 2014 Apr; 96(2):242-9. PubMed ID: 24594117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of microRNAs in coronary atherosclerotic plaque.
    Berkan Ö; Arslan S; Lalem T; Zhang L; Şahin NÖ; Aydemir EI; Korkmaz Ö; Eğilmez HR; Çekin N; Devaux Y
    Epigenomics; 2019 Sep; 11(12):1387-1397. PubMed ID: 31596136
    [No Abstract]   [Full Text] [Related]  

  • 13. miR-199a-5p silencing regulates the unfolded protein response in chronic obstructive pulmonary disease and α1-antitrypsin deficiency.
    Hassan T; Carroll TP; Buckley PG; Cummins R; O'Neill SJ; McElvaney NG; Greene CM
    Am J Respir Crit Care Med; 2014 Feb; 189(3):263-73. PubMed ID: 24299514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA expression profile in human coronary smooth muscle cell-derived microparticles is a source of biomarkers.
    de Gonzalo-Calvo D; Cenarro A; Civeira F; Llorente-Cortes V
    Clin Investig Arterioscler; 2016; 28(4):167-77. PubMed ID: 27363781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Egfl7 and miRNA-126-5p in Symptomatic Carotid Artery Disease.
    Sezer Zhmurov Ç; Timirci-Kahraman Ö; Amadou FZ; Fazlıoğulları O; Başaran C; Catal T; Zeybek Ü; Bermek H
    Genet Test Mol Biomarkers; 2016 Mar; 20(3):125-9. PubMed ID: 26799121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
    Gao W; Chan JY; Wong TS
    Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of differently expressed microRNAs in keloid and pilot study on biological function of miR-199a-5p].
    Wu ZY; Lu L; Guo XR; Zhang PH
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Jul; 29(4):279-84. PubMed ID: 24228510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans.
    Bidzhekov K; Gan L; Denecke B; Rostalsky A; Hristov M; Koeppel TA; Zernecke A; Weber C
    Thromb Haemost; 2012 Apr; 107(4):619-25. PubMed ID: 22370758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.
    Tsuchiyama K; Ito H; Taga M; Naganuma S; Oshinoya Y; Nagano K; Yokoyama O; Itoh H
    Prostate; 2013 Jun; 73(8):827-34. PubMed ID: 23184537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.
    Jansen F; Yang X; Proebsting S; Hoelscher M; Przybilla D; Baumann K; Schmitz T; Dolf A; Endl E; Franklin BS; Sinning JM; Vasa-Nicotera M; Nickenig G; Werner N
    J Am Heart Assoc; 2014 Oct; 3(6):e001249. PubMed ID: 25349183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.